BRISBANE, Calif.--(BUSINESS WIRE)--June 14, 2006--Tercica, Inc. (Nasdaq:TRCA - News) today announced that it has signed distribution agreements with Biologix FZ Co. and Giddi Pharma Co. to begin distributing Increlex(TM) (mecasermin (rDNA origin) injection) in 17 Middle East and North African countries, and Taiwan, respectively. The first commercial shipment of Increlex to Taiwan was made June 12, 2006.
